‌

US Patent 9126951 Inhibitors of the fibroblast growth factor receptor

Patent 9126951 was granted and assigned to Blueprint Medicines on September, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Current Assignee

Blueprint Medicines

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

September 8, 2015

Patent Application Number

14318149

Date Filed

June 27, 2014

Patent Citations Received

US Patent 12060354 Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making

0

US Patent 11963958 RET inhibitor for use in treating cancer having a RET alteration

0

US Patent 11964980 Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1- f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making

0

US Patent 11999744 Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making

0

US Patent 11872192 RET inhibitor for use in treating cancer having a RET alteration

0

Patent Primary Examiner

James O. Wilson

Patent abstract

Described herein are inhibitors of FGFR, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions to inhibit the activity of tyrosine kinases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9126951 Inhibitors of the fibroblast growth factor receptor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.